In this seventh episode, Nathan Price, Professor & Associate Director of the Institute for Systems Biology, explains the concept and aspiration of 'scientific wellness'. He predicts that it will become the dominant paradigm of 21st century healthcare. He explains ‘personal, dense, dynamic data clouds’ will enable both peak wellness and disease avoidance. Possibilities that China may leapfrog the United States.
Lee: Hello, Nathan. Welcome to the seventh episode of the Hyper Wellbeing podcast. Nathan: Lee, it’s great to be with you. Lee: Appreciate it. The last time I saw you was at Hyper Wellbeing 2016 where you gave a keynote. That was greatly appreciated. Nathan: It was a great meeting. Thanks for organizing. Lee: Nathan, can you do a favor... Read MoreISB’s Nathan Price on ‘scientific wellness’ as dominant paradigm of 21st century healthcare
In this sixth episode, Tommy Wood, CSO Nourish Balance Thrive, explains that the majority of modern disease is caused by our environment and as such, under our control. He shares his experience that A.I. coupled with ordinary blood tests, can inform us of changes we can make to protect/optimize our health, or when sick, lower the cost by predicting which further tests to conduct.
Lee: Hello, and welcome to the Hyper Wellbeing podcast, Tommy. Tommy: Oh, thanks for having me. Lee: Tommy, let’s just jump in here. You still look young, you’ve got a fantastic resume, or as the British would say, I think, curriculum vitae. Where is the motivation coming from? What’s your driving force? What’s the mission you’re on? Tommy: I guess... Read MoreNBT’s Tommy Wood on engineering sustained health using A.I. & standard blood chemistry (transcript)
In this fifth episode, Don Brown, CEO LifeOmic, explains the nomenclature shift from precision medicine to precision health, details the firm footing his company has in precision health, how it’s now extending another foot forwards into hyper wellbeing. Lots of app, lifestyle medicine, lifespan, healthspan and biological age quantification chat.
Lee: Hi, so you’re CEO of LifeOmic, a company which I have been tracking for some time. Could you be so kind as to introduce, to give a brief introduction to LifeOmic? Don: Yeah, I started LifeOmic almost two or so years ago. I went through a combined degree in the PhD program many years ago and ended up taking... Read MoreLifeOmic’ Don Brown on precision medicine vs precision health vs hyper wellbeing (transcript)
In this fourth episode, Ardy Arianpour, CEO of Seqster, shares why the future of your health data is a centralized view, controlled by you, pulled from wearables, genetic tests, logged nutritional intake as well as your medical records even if spread across institutions. He relates the unique need and ability to share our lifetime of health data transgenerationally.
Lee: Hello and welcome to the fourth episode of the Hyper Wellbeing podcast. On today’s show we have Ardy Arianpour. Ardy is the CEO and co-founder of Seqster. Ardy is a visionary genomics executive and serial entrepreneur in the biotech industry. Prior to starting Seqster, Ardy launched several clinical and consumer-based genetic test as CCO of Pathway Genomics and SVP... Read MoreSeqster’ Ardy Arianpour on the future of owning, storing & sharing your health data (transcript)
In this third episode, Ivor Cummins, Chief Program Manager of IHDA, shares why as a top class engineer he found himself decoding the causes of human chronic disease and obesity. He relates why healthcare is putting our health and lives at risk. He imparts what we can do to better predict and prevent modern disease.
Lee: Hello and welcome to the third episode of the Hyper Wellbeing podcast. On today’s show we have Ivor Cummins. Ivor is a top class engineer with over 25 years’ experience. His specialty is leading teams in complex problem-solving efforts. Over the past six years, Ivor has applied his technical expertise to decoding the causes of human chronic disease and... Read MoreIHDA’ Ivor Cummins – an engineer’s guide to staying alive for longer & preventing disease (transcript)